The WasteWatcher
The WasteWatcherIRS Survey on Tax Preparation Software Misleads Taxpayers
The Treasury Inspector General for Tax Administration finds fault with design and results of IRS's new direct file system survey.
The WasteWatcherThe FDA Is Adopting California’s Failed Policies on Tobacco
The FDA's proposal to ban menthol-flavored tobacco will put consumers at risk with illicit products.
The WasteWatcherBiden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
The WasteWatcherExpanding Dodd-Frank is a Bad Deal for Consumers
The Credit Card Competition Act of 2023 would increase government interference and harm consumers.
The WasteWatcherGAO Releases New Estimate of COVID Unemployment Insurance Fraud
Congress and executive branch agencies should continue to get as many answers and money as possible.
The WasteWatcherFCC Should Avoid Another Net Neutrality Debacle
Former Obama administration solicitors general agree net neutrality rules should not be restored.
The WasteWatcherThe War on Tobacco Harm Reduction Products Will Continue to Fail
Banning tobacco harm reduction products put consumers at risk with illicit products.
The WasteWatcherBEAD Funding Requires Closer Scrutiny
A new report from Sen. Ted Cruz (R-Texas) spotlights the potential for waste, fraud, and abuse in federal broadband funding.
The WasteWatcherCA Legislature and Gov. Newsom Should Reject Raising Taxes to Subsidize Strikers
SB 799 would extend unemployment benefits to workers on strike, delay the state's debt repayment, and raise payroll tax rates.
The WasteWatcherWealthy Counties Still Flush with COVID Cash
Local governments continue to spend left-over "fiscal recovery" funds on wish list projects with no accountability from Congress.
The WasteWatcherUSF Reforms Should Include Replacing Lifeline with ACP
The Council for Citizens Against Government Waste offered its views on Universal Service reform to Congress on August 24, 2023.
The WasteWatcherThe 340B Drug Discount Program Needs an Overhaul
CAGW has long been concerned with the misuse of the 340B Program.
